A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis

Activation of Sirtuin (silent mating type information regulation 2 homolog) 1, or SIRT1, is an unexplored therapeutic approach for treatment of inflammatory diseases. We randomized 40 patients with moderate-to-severe psoriasis (4:1) to three escalating doses of SRT2104, a selective activator of SIRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Krueger, James G., Suárez-Fariñas, Mayte, Cueto, Inna, Khacherian, Artemis, Matheson, Robert, Parish, Lawrence C., Leonardi, Craig, Shortino, Denise, Gupta, Akanksha, Haddad, Jonathan, Vlasuk, George P., Jacobson, Eric W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640558/
https://www.ncbi.nlm.nih.gov/pubmed/26556603
http://dx.doi.org/10.1371/journal.pone.0142081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640558/
https://www.ncbi.nlm.nih.gov/pubmed/26556603
http://dx.doi.org/10.1371/journal.pone.0142081

Ejemplares similares